Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Torti

Showing results (71-80 of 278) with videos related to

Pageof 28
Sort By:
The Journal of Urology|October 1, 1988
Brain metastases from transitional cell carcinoma of the bladderJ N Kabalin, F S Freiha, F M Torti
Drug Intelligence & Clinical Pharmacy|April 1, 1985
Doxorubicin: alteration of dose scheduling as a means of reducing cardiotoxicityB L Lum, J M Svec, F M Torti
Progress in Clinical and Biological Research|January 1, 1984
Community vs. university physician performance and patient evaluabilityP Jackson, M Koretz, J Hannigan, et al.
Current Problems in Cancer|November 1, 1988
Carcinoma of the prostate: pathology, staging, and treatmentF S Freiha, M A Bagshaw, F M Torti
Hematology/Oncology Clinics of North America|December 1, 1991
Serum markers in germ cell neoplasmsN L Bartlett, F S Freiha, F M Torti
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 12, 2006
Analytic considerations in economic evaluations of multinational cardiovascular clinical trialsFrank M Torti, Shelby D Reed, Kevin A Schulman
FEBS Letters|November 24, 1999
Adenovirus E1A blocks oxidant-dependent ferritin induction and sensitizes cells to pro-oxidant cytotoxicityK Orino, Y Tsuji, F M Torti, et al.
Biochemical Pharmacology|April 14, 2010
Ferritin H induction by histone deacetylase inhibitorsWei Wang, Xiumin Di, Suzy V Torti, et al.
Cancer|October 15, 1987
Failure of adjuvant chemotherapy in testicular cancerJ I Bernstein, F Freiha, J Breeden, et al.
FEBS Letters|August 7, 1999
Hydrolysis of NADP+ by platelet CD38 in the absence of synthesis and degradation of cyclic ADP-ribose 2'-phosphateM Torti, A Bertoni, I Canobbio, et al.
Pageof 28

Showing results (71-80 of 278) with videos related to

Sort By:
Pageof 28
The Journal of Urology|October 1, 1988
Brain metastases from transitional cell carcinoma of the bladderJ N Kabalin, F S Freiha, F M Torti
Drug Intelligence & Clinical Pharmacy|April 1, 1985
Doxorubicin: alteration of dose scheduling as a means of reducing cardiotoxicityB L Lum, J M Svec, F M Torti
Progress in Clinical and Biological Research|January 1, 1984
Community vs. university physician performance and patient evaluabilityP Jackson, M Koretz, J Hannigan, et al.
Current Problems in Cancer|November 1, 1988
Carcinoma of the prostate: pathology, staging, and treatmentF S Freiha, M A Bagshaw, F M Torti
Hematology/Oncology Clinics of North America|December 1, 1991
Serum markers in germ cell neoplasmsN L Bartlett, F S Freiha, F M Torti
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 12, 2006
Analytic considerations in economic evaluations of multinational cardiovascular clinical trialsFrank M Torti, Shelby D Reed, Kevin A Schulman
FEBS Letters|November 24, 1999
Adenovirus E1A blocks oxidant-dependent ferritin induction and sensitizes cells to pro-oxidant cytotoxicityK Orino, Y Tsuji, F M Torti, et al.
Biochemical Pharmacology|April 14, 2010
Ferritin H induction by histone deacetylase inhibitorsWei Wang, Xiumin Di, Suzy V Torti, et al.
Cancer|October 15, 1987
Failure of adjuvant chemotherapy in testicular cancerJ I Bernstein, F Freiha, J Breeden, et al.
FEBS Letters|August 7, 1999
Hydrolysis of NADP+ by platelet CD38 in the absence of synthesis and degradation of cyclic ADP-ribose 2'-phosphateM Torti, A Bertoni, I Canobbio, et al.
Pageof 28